Record High Net Revenue
Rubicon Organics achieved record high net revenue for both the 3-month and 12-month periods ending December 31, 2024, up 21% and 42% respectively compared to 2023.
Positive Adjusted EBITDA
Reported positive adjusted EBITDA of $4 million, excluding $900,000 in one-off ERP implementation costs, with a record high profitability of $5 million without the costs.
Market Share Leadership
Rubicon holds over 6% market share of the Canadian premium market, with leading positions in the premium medical cannabis segment at 30% market share within a year of launch.
Vape Product Success
Successfully launched a vape product line, achieving over 13% national market share and 56% national distribution in six months.
International Expansion
Received GACP certification for the Delta facility, allowing Rubicon to execute inaugural international shipment to Poland and enter into an agreement to acquire a new facility in Hope, BC.
Awards and Recognition
Swept the 2024 KIND Magazine Awards with 11 accolades and won Vape of the Year and Best New Product.
Strong Operating Cash Flows
Operating cash flows improved to $2.3 million in Q4 2024, marking the third year of positive operating cash flows.
Strategic Acquisition
Acquired a new facility in Hope, BC, expanding annual production capacity by over 40% to 15,500 kilos.